AR069740A1 - Compuestos nucleosidos antivirales - Google Patents

Compuestos nucleosidos antivirales

Info

Publication number
AR069740A1
AR069740A1 ARP080105126A ARP080105126A AR069740A1 AR 069740 A1 AR069740 A1 AR 069740A1 AR P080105126 A ARP080105126 A AR P080105126A AR P080105126 A ARP080105126 A AR P080105126A AR 069740 A1 AR069740 A1 AR 069740A1
Authority
AR
Argentina
Prior art keywords
alkyl
alkoxy
pyridinyl
heteroaryl
cycloalkyl
Prior art date
Application number
ARP080105126A
Other languages
English (en)
Inventor
David Bernard Smith
Brett C Bookser
Scott J Hecker
Zhili Sun
K Raja Reddy
Original Assignee
Metabasis Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40679083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR069740(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Metabasis Therapeutics Inc filed Critical Metabasis Therapeutics Inc
Publication of AR069740A1 publication Critical patent/AR069740A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Abstract

Son inhibidores de la polimerasa NS5b del virus de la hepatitis C. También se describen composiciones y métodos para el tratamiento de una infeccion por VHC y que inhiben la replicacion de VHC3. Reivindicacion 1: Un compuesto con la formula general (1) o (2) en el que y es fenilo o piridinilo, estando dicho fenilo o piridinilo opcionalmente sustituido con uno a tres sustituyentes seleccionado de entre el grupo que consiste en halogeno, alquilo C1-6, haloalquilo C1-6, alcoxi C1-6, o ciano; B es (B-1), (B-2) o (B-3); R1 y R2 se seleccionan independientemente a partir de H y/o COR4; Y es O o NH; R3 es alquilo C1-6 o COR4 y, R4 es alquilo C1-6, alcoxi C1-3 alquilo -C1-6, cicloalquilo C3-6, cicloalquil C3-6 alquilo -C1-3, alcoxi C1-6 o heteroarilo en la que el heteroarilo es un anillo de cinco miembros que contiene uno o dos heteroátomos seleccionados de nitrogeno, oxígeno o azufre o piridina o un anillo de seis miembros con uno o dos átomos de nitrogeno; o, una sal farmacéuticamente aceptable de los mismos.
ARP080105126A 2007-11-29 2008-11-26 Compuestos nucleosidos antivirales AR069740A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99116307P 2007-11-29 2007-11-29
US8454408P 2008-07-29 2008-07-29

Publications (1)

Publication Number Publication Date
AR069740A1 true AR069740A1 (es) 2010-02-17

Family

ID=40679083

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080105126A AR069740A1 (es) 2007-11-29 2008-11-26 Compuestos nucleosidos antivirales

Country Status (20)

Country Link
US (2) US8063025B2 (es)
EP (1) EP2227481A4 (es)
JP (1) JP2011505351A (es)
KR (1) KR20100103793A (es)
CN (1) CN102164939A (es)
AR (1) AR069740A1 (es)
AU (1) AU2008331158A1 (es)
BR (1) BRPI0819797A2 (es)
CA (1) CA2706432A1 (es)
CL (1) CL2008003511A1 (es)
CO (1) CO6382185A2 (es)
CR (1) CR11453A (es)
EC (1) ECSP10010210A (es)
IL (1) IL205625A0 (es)
MA (1) MA31864B1 (es)
MX (1) MX2010005885A (es)
RU (1) RU2010126050A (es)
TW (1) TW200936146A (es)
WO (1) WO2009069095A2 (es)
ZA (1) ZA201003438B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2225238E (pt) 2007-11-29 2014-12-18 Boehringer Ingelheim Int Derivados de amidas do ácido 6,7-di-hidro-5h-imidazo[1,2- a]imidazol-3-carboxílico
MX337050B (es) 2010-01-28 2016-02-10 Riboscience Llc Compuestos 4'-azido-nucleósidos como anti-vhc.
CA2812962C (en) 2010-09-22 2020-03-31 Alios Biopharma, Inc. Azido nucleosides and nucleotide analogs
TW201242974A (en) 2010-11-30 2012-11-01 Gilead Pharmasset Llc Compounds
EP2776438A4 (en) * 2011-11-10 2015-04-29 Inhibitex Inc SUBSTITUTED PURIN NUCLEOSIDES, PHOSPHORAMIDATE AND PHOSPHORDIAMIDATE DERIVATIVES FOR THE TREATMENT OF VIRUS INFECTIONS
WO2015077368A1 (en) 2013-11-22 2015-05-28 Ligand Pharmaceuticals Incorporated Derivatives of uridine 5'-cyclophosphate useful to treat hepatitis c viral infections
CN103848877B (zh) * 2013-12-16 2016-08-24 安徽贝克联合制药有限公司 核苷环磷酸酯化合物及其制备方法和其应用
US10449210B2 (en) 2014-02-13 2019-10-22 Ligand Pharmaceuticals Inc. Prodrug compounds and their uses
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
WO2017024255A1 (en) 2015-08-05 2017-02-09 Metrobiotech, Llc Nicotinamide mononucleotide derivatives and their uses
WO2018129039A1 (en) 2017-01-04 2018-07-12 President And Fellows Of Harvard College Modulating nudix homology domain (nhd) with nicotinamide mononucleotide analogs and derivatives of same
CN108727450B (zh) * 2017-04-18 2024-02-20 浙江柏拉阿图医药科技有限公司 肝递送抗丙肝前体药物核苷环磷酸酯化合物及应用
CN109956986B (zh) * 2017-12-22 2021-04-27 浙江柏拉阿图医药科技有限公司 肝递送吉西他滨前体药物核苷环磷酸酯化合物及应用
CN109956985A (zh) * 2017-12-22 2019-07-02 浙江柏拉阿图医药科技有限公司 肝递送阿糖胞苷前体药物核苷环磷酸酯化合物及应用
CN109956975B (zh) * 2017-12-22 2020-11-06 浙江柏拉阿图医药科技有限公司 肝递送恩替卡韦前体药物核苷环磷酸酯化合物及应用
CN111434671B (zh) * 2019-01-11 2023-07-11 凯思凯迪（上海）医药科技有限公司 肝脏特异性ampk激动剂及其制法和应用
TW202322824A (zh) 2020-02-18 2023-06-16 美商基利科學股份有限公司 抗病毒化合物
AU2022256476A1 (en) 2021-04-16 2023-10-12 Gilead Sciences, Inc. Methods of preparing carbanucleosides using amides

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU767599B2 (en) * 1998-03-06 2003-11-20 Metabasis Therapeutics, Inc. Novel prodrugs for phosphorus-containing compounds
GB0114286D0 (en) * 2001-06-12 2001-08-01 Hoffmann La Roche Nucleoside Derivatives
BR0315806A (pt) 2002-10-31 2005-09-13 Metabasis Therapeutics Inc Fosfato diésteres cìclicos de 1,3-propano-1-aril diós e seu uso na preparação de pró-drogas
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
ES2351603T3 (es) 2003-07-25 2011-02-08 Idenix Pharmaceuticals, Inc. Análogos de nucleósidos de purina para el tratamiento de enfermedades causadas por flaviridae incluyendo hepatitis c.
JP2008508319A (ja) 2004-07-29 2008-03-21 メタバシス・セラピューティクス・インコーポレイテッド 新規ヌクレオシド誘導体
EP1928475B1 (en) * 2005-08-15 2018-05-23 Riboscience LLC Antiviral phosphoramidates of 4'-c-azido-substituted pronucleotides
JP4954573B2 (ja) * 2006-02-28 2012-06-20 オリンパス株式会社 内視鏡システム

Also Published As

Publication number Publication date
JP2011505351A (ja) 2011-02-24
WO2009069095A3 (en) 2009-12-23
AU2008331158A1 (en) 2009-06-04
WO2009069095A2 (en) 2009-06-04
RU2010126050A (ru) 2012-01-10
CN102164939A (zh) 2011-08-24
US20090209481A1 (en) 2009-08-20
EP2227481A2 (en) 2010-09-15
ECSP10010210A (es) 2010-08-31
US20120039845A1 (en) 2012-02-16
CR11453A (es) 2010-10-27
CA2706432A1 (en) 2009-06-04
CO6382185A2 (es) 2012-02-15
TW200936146A (en) 2009-09-01
MA31864B1 (fr) 2010-11-01
IL205625A0 (en) 2010-11-30
EP2227481A4 (en) 2011-03-09
MX2010005885A (es) 2010-11-24
ZA201003438B (en) 2011-04-28
CL2008003511A1 (es) 2010-02-19
US8063025B2 (en) 2011-11-22
KR20100103793A (ko) 2010-09-28
BRPI0819797A2 (pt) 2019-09-24

Similar Documents

Publication Publication Date Title
AR069740A1 (es) Compuestos nucleosidos antivirales
EA200800476A1 (ru) Макроциклические ингибиторы вируса гепатита с
EA200970493A1 (ru) Макроциклические ингибиторы вируса гепатита с
AR066492A1 (es) Derivados de imidazoquinolina, proceso para su preparacion, composiciones farmaceuticas que los contienen y usos para el tratamiento de enfermedades virales, bacterianas, alergicas y distintos tipos de canceres.
AR052559A1 (es) Derivados de pirazol para inhibir cdk's y gsk's
CO6160231A2 (es) Compuestos de isoindolina 5-substituidos
EA200800477A1 (ru) Макроциклические ингибиторы вируса гепатита с
PE20090511A1 (es) Imidazopiridinonas
AR082696A1 (es) Derivados heterociclicos nitrogenados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades cardiovasculares e inflamatorias, entre otras
ES2570127T3 (es) Compuestos y composiciones como inhibidores de la proteína quinasa
AR057703A1 (es) INHIBIDORES MACROCíCLICOS DEL VIRUS DE LA HEPATITIS C. PROCESO DE PREPARACIoN Y COMPOSICIONES FARMACÉUTICAS.
AR054882A1 (es) Inhibidores macrociclicos del virus de la hepatitis c
RU2012140961A (ru) ПРОИЗВОДНОЕ 1,3,4,8-ТЕТРАГИДРО-2Н-ПИРИДО[1,2-a]ПИРАЗИНА И ЕГО ПРИМЕНЕНИЕ В КАЧЕСТВЕ ИНИБИТОРА ИНТЕГРАЗЫ ВИЧ
AR079231A1 (es) Derivados de imidazoquinolina
AR084588A1 (es) Compuesto heterociclico fusionado y su uso para el control de plagas
CO6251260A2 (es) Derivados de bifenilo conformacionalmente restringido para uso como inhibidores del virus de la hepatitis c.
ES2613538T3 (es) Derivados de arilamida como bloqueadores de TTX-S
AR086546A1 (es) Derivados de 7h-purin-8(9h)-ona como inhibidores de jak
AR070361A1 (es) Compuestos heterociclicos antiviricos
AR076579A1 (es) Espironucleosidos uracilicos oxetanicos, composiciones farmaceuticas que los contienen y uso de los mismos como inhibidores del virus de la hepatitis c (vhc).
AR047056A1 (es) Derivados de pirimidinas condensadas. composiciones farmacéuticas
AR056445A1 (es) Derivados arilicos y heteroarilicos de 6 miembros para tratar virus
AR074504A1 (es) Nucleotidos uracil ciclopropilicos
AR062258A1 (es) Compuestos heterociclicos condensados de tieno-pirrol, composiciones farmaceuticas que los contienen y usos para el tratamiento de infecciones por hcv
AR059621A1 (es) Acidos 4- fenil- tiazol-5- carboxilicos y amidas de acidos 4- fenil- tiazol5 carboxilicos como inhibidores de la plk1

Legal Events

Date Code Title Description
FA Abandonment or withdrawal